Download presentation
Presentation is loading. Please wait.
Published byYanti Hartanto Modified over 5 years ago
1
Evaluation of an ultra-low-dose oral contraceptive for dysmenorrhea: a placebo- controlled, double-blind, randomized trial Tasuku Harada, M.D., Mikio Momoeda, M.D. Fertility and Sterility Volume 106, Issue 7, Pages (December 2016) DOI: /j.fertnstert Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions
2
Figure 1 Flow diagram of the randomized, controlled trial.
Fertility and Sterility , DOI: ( /j.fertnstert ) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions
3
Figure 2 Changes in the mean (±SE) dysmenorrhea and VAS scores from the pretreatment cycle to cycle 5 in the patients with (A) dysmenorrhea, (B) primary dysmenorrhea, and (C) secondary dysmenorrhea. *P<.05, **P<.01 for NPC-01 vs. placebo. Fertility and Sterility , DOI: ( /j.fertnstert ) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions
4
Figure 3 Changes in the incidence rate of irregular uterine bleeding (not spotting) from the first treatment cycle to the fourth treatment cycle. Fertility and Sterility , DOI: ( /j.fertnstert ) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.